---
reference_id: "PMID:36547989"
title: Tecovirimat Treatment for Monkeypox Virus Keratouveitis.
authors:
- Finamor LPS
- de Freitas D
- Andrade G
- Bergamasco VD
- Cunha L
- Lázari C
- Muccioli C
journal: JAMA Ophthalmol
year: '2023'
doi: 10.1001/jamaophthalmol.2022.5486
content_type: abstract_only
---

# Tecovirimat Treatment for Monkeypox Virus Keratouveitis.
**Authors:** Finamor LPS, de Freitas D, Andrade G, Bergamasco VD, Cunha L, Lázari C, Muccioli C
**Journal:** JAMA Ophthalmol (2023)
**DOI:** [10.1001/jamaophthalmol.2022.5486](https://doi.org/10.1001/jamaophthalmol.2022.5486)

## Content

1. JAMA Ophthalmol. 2023 Feb 1;141(2):210-212. doi: 
10.1001/jamaophthalmol.2022.5486.

Tecovirimat Treatment for Monkeypox Virus Keratouveitis.

Finamor LPS(1)(2)(3), de Freitas D(1), Andrade G(1)(2)(3)(4), Bergamasco 
VD(1)(2)(3), Cunha L(2)(3), Lázari C(3)(5), Muccioli C(1).

Author information:
(1)Department of Ophthalmology and Visual Sciences, Paulista School of Medicine, 
Federal University of São Paulo, São Paulo, Brazil.
(2)Moacir Cunha Eye Clinic, São Paulo, Brazil.
(3)Fleury Group, São Paulo, Brazil.
(4)Department of Ophthalmology, Santa Casa de São Paulo, São Paulo, Brazil.
(5)Molecular Biology Laboratory University of São Paulo, School of Medicine, São 
Paulo, Brazil.

Plain Language Summary: This case report describes tecovirimat treatment for a 
patient with monkeypox virus–related keratouveitis.

DOI: 10.1001/jamaophthalmol.2022.5486
PMID: 36547989 [Indexed for MEDLINE]